Duration of immunosuppressive therapy in autoimmune hepatitis [2]

Journal of Hepatology

Volumn 34, Issue 2, 2001, Pages 354-355

  Kanzler, Stephan ^a   Gerken, Guido ^b   Löhr, Hanns ^a   Galle, Peter Robert ^a   Meyer zum Büschenfelde, Karl Hermann ^a   Lohse, Ansgar Wilhelm ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; AUTOIMMUNE HEPATITIS; CLINICAL TRIAL; DISEASE EXACERBATION; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; SCHOOL CHILD;

EID: 0035117791     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)00095-7     Document Type: Letter

References (5)

1. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis
2. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis
3. Clinical and prognostic implications of H.L.A. B8 in corticosteroid-treated severe autoimmune chronic active hepatitis
4. Sustained remission after corticosteroid therapy of severe HBs antigen-negative chronic active hepatitis
5. Autoimmune hepatitis in childhood: A 20-year experience